GlassScriptPhysician profile
Nicholas Molacek
NPI 1164840823
$272.74
in general payments reported to CMS, 2019-2025
10 companies · $97.34 in 2025
The $97.34 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.64 · 2023: $65.40 · 2024: $90.36 · 2025: $97.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $76.49 | 2023-2024 | Signia, Progrip |
| Ethicon US, LLC | $33.95 | 2025 | Ethicon, Stratafix, Vistaseal |
| Innovation Technologies INC | $33.48 | 2023 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $25.92 | 2025 | |
| Reprise Biomedical, INC. | $23.55 | 2025 | Miro3d |
| Innocoll Pharmaceuticals Limited | $19.64 | 2021 | |
| Davol INC. | $17.82 | 2024 | Phasix Mesh |
| Genzyme Corporation | $14.88 | 2024 | |
| Abbvie INC. | $13.92 | 2025 | |
| Braintree Laboratories, INC. | $13.09 | 2023 | Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Molacek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.